FDA Adverse Event Summary report: N

SCULPTRA

MDR report key: 1733896 · Received December 21, 2009

Report

Report Number
3002807108-2009-00818
Date Received
December 21, 2009
Date of Event
April 25, 2009
Report Date
April 27, 2009
Manufacturer
GLOBAL PHARMACOVIGILANCE AND EPIDEMIOLOGY/SANOFI-AVENTIS
Product Code
LMH
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FI
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A PTC (PHARMACEUTICAL TECHNICAL COMPLAINT) WAS INITIATED: GLOBAL PTC NUMBER (B)(4). ADDENDUM FOR F/U INFO RECEIVED ON (B)(6) 2009: PTC RESULTS FOR BATCH A8025 REVEALED: BRR (BATCH RECORD REVIEW) WITHOUT HINT TO ROOT CAUSE. NO FAULTS, DEFECTS, DAMAGES DETECTABLE. THE REVIEW OF THE DHR (DEVICE HISTORY RECORDS) AND OF THE ANALYTICAL RESULTS OF THE INVOLVED BATCH DIDN'T' SHOW ANY ANOMALY THAT COULD BE RELATED TO THE EVENT OCCURRED. THE INVESTIGATION RESULTS SHOW THAT THIS KIND OF EVENT ISN'T BATCH RELATED. CONCLUSION: NO FAULTS DETECTABLE.

Description of Event or Problem · 1

(B)(4). INITIAL REPORT: THIS NON-SERIOUS SPONTANEOUS CASE REPORT FROM (B)(6) WAS REPORTED BY A PHYSICIAN THROUGH THE COMPANY OTC BRAND MANAGER AND FORWARDED BY OUR LOCAL AFFILIATE ((B)(4)). THIS CASE INVOLVES A FEMALE PT (AGE NOS) WHO RECEIVED HER FIRST TREATMENT OF POLY-L-LACTIC ACID (SCULPTRA) THERAPY ON (B)(6) 2009. LIDOCAINE, A DISINFECTANT (NOS), AND AVENE SKIN RECOVERY CREAM WERE USED DURING THIS TREATMENT, BUT WERE NOT SUSPECTED. ADD'L CONCOMITANT MEDICATIONS AND RELEVANT MEDICAL HISTORY WERE NOT MENTIONED. ON (B)(6) 2009, THE PT EXPERIENCED REDNESS, SWELLING, AND SEVERE ITCHING OF THE FACE. CORRECTIVE TREATMENT BY THE DERMATOLOGIST INCLUDED CORTISONE INJECTIONS AND AN ORAL ANTIHISTAMINE. THE PT RECOVERED FROM THIS EVENT ON (B)(6) 2009. THE REPORTER SUSPECTED THAT THE EVENT WAS RELATED TO POLY-L-LACTIC ACID THERAPY, BUT ALSO ASKED THE PT TO CHANGE THE CREAM THAT SHE HAD USED FOR SKIN MASSAGE TO ANOTHER PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SCULPTRA WRINKLE FILLER LMH GLOBAL PHARMACOVIGILANCE AND EPIDEMIOLOGY/SANOFI-AVENTIS NA A8025

Patients

Seq Age Sex Outcome Treatment
1 UNK